Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats

Alcohol

Volumn 46, Issue 1, 2012, Pages 17-27

  Dhaher, Ronnie ^a   Toalston, Jamie E ^b,c   Hauser, Sheketha R ^b   Bell, Richard L ^b,c   McKinzie, David L ^d   McBride, William J ^b   Rodd, Zachary A ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Alcohol deprivation effect; Alcohol relapse; Alcohol seeking; Ethanol reinforcement; Operant; Pavlovian Spontaneous Recovery

Indexed keywords

ALCOHOL; LY 255582; NALTREXONE; OPIATE ANTAGONIST; UNCLASSIFIED DRUG; WATER;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRINKING; DRINKING BEHAVIOR; DRUG SELF ADMINISTRATION; FACTORIAL ANALYSIS; FEMALE; INSTRUMENTAL CONDITIONING; NONHUMAN; RAT; RELAPSE;

ALCOHOL DRINKING; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; CYCLOHEXANES; DRUG-SEEKING BEHAVIOR; ETHANOL; EXTINCTION, PSYCHOLOGICAL; FEMALE; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERIDINES; RATS; RECURRENCE;

RATTUS; RODENTIA;

EID: 84855558806     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2011.08.011     Document Type: Article

References (74)

1. Akala E.O., Wang H., Adedoyin A. Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats. Neuropsychobiology 2008, 58:81-90.
2. Anton R.F. What is craving? Models and implications for treatment. Alcohol Res. Health 1999, 23:165-173.
3. Assanangkornchai S., Srisurapanont M. The treatment of alcohol dependence. Curr. Opin. Psychiatry 2007, 20:222-227.
4. Bäckström P., Hyytiä P. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol. Clin. Exp. Res. 2004, 28:558-565.
5. Badia-Elder N.E., Mosemiller A.K., Elder R.L., Froehlich J.C. Naloxone retards the expression of a genetic predisposition toward alcohol drinking. Psychopharmacology 1999, 144:205-212.
6. Bespalov A.Y., Tokarz M.E., Bowen S.E., Balster R.L., Beardsley P.M. Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice. Psychopharmacology 1999, 141:118-122.
7. Boyle A.E., Stewart R.B., Macenski M.J., Spiga R., Johnson B.A., Meisch R.A. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol. Clin. Exp. Res. 1998, 22:359-366.
8. Burattini C., Gill T.M., Aicardi G., Janak P.H. The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone. Neuroscience 2006, 139:877-887.
9. Ciccocioppo R., Lin D., Martin-Fardon R., Weiss F. Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone. Psychopharmacology 2003, 168:208-215.
10. Ciccocioppo R., Martin-Fardon R., Weiss F. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 2002, 27:391-399.
11. Cowen M.S., Rezvani A.H., Jarrott B., Lawrence A.J. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density. Alcohol. Clin. Exp. Res. 1999, 23:1008-1014.
12. Czachowski C.L., Delory M.J. Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats. Psychopharmacology 2009, 204:335-348.
13. Dayas C.V., Liu X., Simms J.A., Weiss F. Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol. Psychiatry 2007, 61:979-989.
14. Domjan M., Burkhard B. The Principles of Learning and Behavior 1982, Brooks Cole Publishing, Monterey, CA.
15. Emmerson P.J., McKinzie J.H., Surface P.L., Suter T.M., Mitch C.H., Statnick M.A. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists. Eur. J. Pharmacol. 2004, 494:121-130.
16. Escher T., Mittleman G. Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone. Addict. Biol. 2006, 11:55-63.
17. Gackenheimer S.L., Suter T.M., Pintar J.E., Quimby S.J., Wheeler W.J., Mitch C.H., et al. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites. Neuropeptides 2005, 39:559-567.
18. Gilpin N.W., Richardson H.N., Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 2008, 32:1535-1542.
19. Grahame N.J., Mosemiller A.K., Low M.J., Froehlich J.C. Naltrexone and alcohol drinking in mice lacking beta-endorphin by site-directed mutagenesis. Pharmacol. Biochem. Behav. 2000, 67:759-766.
20. Häggkvist J., Lindholm S.F. J The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addict. Biol. 2009, 14:260-269.
21. Heyser C.J., Moc K., Koob G.F. Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 2003, 28:1463-1471.
22. Hölter S.M., Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 1999, 145:360-369.
23. Ji D., Gilpin N.W., Richardson H.N., Rivier C.L., Koob G.F. Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav. Pharmacol. 2008, 19:1-12.
24. Kamdar N.K., Miller S.A., Syed Y.M., Bhayana R., Gupta T., Rhodes J.S. Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice. Psychopharmacology 2007, 192:207-217.
25. Kiefer S.W., Hill K.G., Coonfield D.L., Ferraro F.M. Ethanol familiarity and naltrexone treatment affect ethanol responses in rats. Alcohol 2005, 37:167-172.
26. Kim S.G., Han B.D., Park J.M., Kim M.J., Stromberg M.F. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry Clin. Neurosci. 2004, 58:30-36.
27. Koistinen M., Tuomainen P., Hyytiä P., Kiianmaa K. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. Alcohol. Clin. Exp. Res. 2001, 25:1605-1612.
28. Kornet M., Goosen C., Van Ree J.M. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 1991, 104:367-376.
29. Krishnan-Sarin S., Krystal J.H., Shi J., Pittman B., O'Malley S.S. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol. Psychiatry 2007, 62:694-697.
30. Kuzmin A., Kreek M.J., Bakalkin G., Liljequist S. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 2007, 32:902-910.
31. Kuzmin A., Stenback T., Liljequist S. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption. Eur. J. Pharmacol. 2008, 584:352-356.
32. Lê A.D., Poulos C.X., Harding S., Watchus J., Juzytsch W., Shaham Y. Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 1999, 21:435-444.
33. Liu X., Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 2002, 22:7856-7861.
34. Macintosh N.J. Stimulus control: attentional factors. Handbook on Operant Behavior 1977, 162-241. Prentice-Hall, Englewood Cliffs, NJ. W.K. Honig, J.E.R. Staddon (Eds.).
35. Marczak E.D., Jinsmaa Y., Li T., Bryant S.D., Tsuda Y., Okada Y., et al. [N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties. J. Pharmacol. Exp. Ther. 2007, 323:374-380.
36. Marinelli P.W., Funk D., Juzytsch W., Li Z., Lê A.D. Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression. Eur. J. Neurosci. 2007, 26:2815-2823.
37. Mhatre M., Pruthi R., Hensley K., Holloway F. 5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake. Eur. J. Pharmacol. 2004, 491:149-156.
38. Mitchell J.M., Bergren L.J., Chen K.S., Rowbotham M.C., Fields H.L. Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. Neurobiol. Dis. 2009, 33:72-80.
39. Modesto-Lowe V., Fritz E.M. The opioidergic-alcohol link: implications for treatment. CNS Drugs 2005, 19:693-707.
40. Mormede P., Colas A., Jones B.C. High ethanol preferring rats fail to show dependence following short- or long-term ethanol exposure. Alcohol Alcohol. 2004, 39:183-189.
41. Myers R.D., Borg S., Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 1986, 3:383-388.
42. Oliva J.M., Manzanares J. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats. Neuropsychopharmacology 2007, 32:1358-1369.
43. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch. Gen. Psychiatry 1992, 49:881-887.
44. Oswald L.M., Wand G.S. Opioids and alcoholism. Physiol. Behav. 2004, 81(2):339-358.
45. Parker L.A., Rennie M. Naltrexone-induced aversions: assessment by place conditioning, taste reactivity, and taste avoidance paradigms. Pharmacol. Biochem. Behav. 1992, 41:559-565.
46. Pavlov I.P. Conditioned Reflexes (G.V. Anrep trans) 1927, Oxford University Press, London.
47. Pellicano M.P., Sadile A.G. Differential alcohol drinking behaviour and dependence in the Naples low- and high-excitability rat lines. Behav. Brain Res. 2006, 171:199-206.
48. Pettinati H.M., O'Brien C.P., Rabinowitz A.R., Wortman S.P., Oslin D.W., Kampman K.M., et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J. Clin. Psychopharmacol. 2006, 26:610-625.
49. Pickering C., Liljequist S. Cue-induced behavioural activation: a novel model of alcohol craving?. Psychopharmacology 2003, 168:307-313.
50. Rezvani A.H., Overstreet D.H., Levin E.D., Rosenthal D.I., Kordik C.P., Reitz A.B., et al. Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats. Alcohol. Clin. Exp. Res. 2007, 31:57-63.
51. Rezvani A.H., Overstreet D.H., Vaidya A.H., Zhao B., Levin E.D. Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats. Alcohol. Clin. Exp. Res. 2009, 33:1366-1373.
52. Rodd Z.A., Bell R.L., Sable H.J., Murphy J.M., McBride W.J. Recent advances in animal models of alcohol craving and relapse. Pharmacol. Biochem. Behav. 2004, 79:439-450.
53. Rodd Z.A., Bell R.L., Zhang Y., Murphy J.M., Goldstein A., Zaffaroni A., et al. Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. Neuropsychopharmacology 2005, 30:330-338.
54. Rodd Z.A., McKinzie D.L., Bell R.L., McQueen V.K., Murphy J.M., Schoepp D.D., et al. The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav. Brain Res. 2006, 171:207-215.
55. Rodd-Henricks Z.A., Bell R.L., Kuc K.A., Murphy J.M., McBride W.J., Lumeng L., et al. Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: II. Adult exposure. Alcohol. Clin. Exp. Res. 2002, 26:1642-1652.
56. Rodd-Henricks Z.A., Bell R.L., Kuc K.A., Murphy J.M., McBride W.J., Lumeng L., et al. Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent exposure. Alcohol. Clin. Exp. Res. 2002, 26:1632-1641.
57. Rösner S., Leucht S., Lehert P., Soyka M. Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J. Psychopharmacol. 2008, 22:11-23.
58. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology 2006, 189:175-186.
59. Sable H.J., Bell R.L., Rodd Z.A., McBride W.J. Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats. Int. J. Adolesc. Med. Health 2006, 18:139-149.
60. Sinclair J.D., Senter R.J. Increased preference for ethanol in rats following deprivation. Psychon. Sci. 1967, 8:11-12.
61. Sinclair J.D., Senter R.J. Development of an alcohol-deprivation effect in rats. Q.J. Stud. Alcohol 1968, 29:863-867.
62. Spanagel R., Kiefer F. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol. Sci. 2008, 29:109-115.
63. Statnick M.A., Tinsley F.C., Eastwood B.J., Suter T.M., Mitch C.H., Heiman M.L. Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:1399-1408.
64. Swanson S.P., Catlow J., Pohland R.C., Chay S.H., Johnson T. Disposition of the opioid antagonist, LY255582, in rats and dogs. Drug Metab. Dispos. 1995, 23:916-921.
65. Tidey J.W., Monti P.M., Rohsenow D.J., Gwaltney C.J., Miranda R., McGeary J.E., et al. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol. Clin. Exp. Res. 2008, 32:58-66.
66. Toalston J.E., Oster S.M., Kuc K.A., Pommer T.J., Murphy J.M., Lumeng L., et al. Effects of alcohol and saccharin deprivations on concurrent ethanol and saccharin operant self-administration by alcohol-preferring (P) rats. Alcohol 2008, 42:277-284.
67. Walker B.M., Koob G.F. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 2008, 33:643-652.
68. Wang D., Raehal K.M., Bilsky E.J., Sadée W. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. J. Neurochem. 2001, 77:1590-1600.
69. Wang D., Sun X., Sadee W. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with andwithout agonist pretreatment. J. Pharmacol. Exp. Ther. 2007, 321:544-552.
70. White D.A., Hwang M.L., Holtzman S.G. Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat. Pharmacol. Biochem. Behav. 2005, 81:451-458.
71. Williams K.L., Schimmel J.S. Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment. Alcohol 2008, 42:553-563.
72. Williams K.L., Winger G., Pakarinen E.D., Woods J.H. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology 1998, 139:53-61.
73. Williams K.L., Woods J.H. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys. Alcohol. Clin. Exp. Res. 1999, 23:708-715.
74. Zalewska-Kaszubska J., Gorska D., Dyr W., Czarnecka E. Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with naltrexone. Physiol. Behav. 2008, 93:1005-1010.